HPGD and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, TAMs prevent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) expression by secreting IL-1β and are associated with poor prognosis of patients [12].